Innoviva (INVA)

• Market cap: $1.57B
• 1 day: -1.94%
• 5 days: -0.89%
• 1 month: -6.56%
• 3 months: -7.7%
• 6 months: 6.1%
• Year to date: 6.79%
• 1 year: 15.14%
• 5 years: 49.65%
• 10 years: 62.73%
• Sector: Healthcare
• Industry: Biotechnology

About: Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.

Employees: 159